India Earnings Season: quick round up
Monday, October 24, 2011
Strides Arcolab Rs 769 crs revenues
Revenues are up 80% from September 2010 of just $82.4 mln to $154 mln with a PAT of 46 cr from 34 crores still a non starter
Annual Guidance has moved to half a billion dollars . Has ramped up capacity based on approvals for Oncology. Forex the conmpany covers 50% of Net Exports (Net exposure)
Ascent Pharma of Australia is reporting in this quarter after the acquisition with 94% STAR ownership
India
0 comments:
Post a Comment